Trending Insights
Frequently Asked Questions
-
What value is the global pharmacogenomics (pgx) market expected to touch by 2033?
The global pharmacogenomics (pgx) market is expected to reach USD 22.76 billion by 2033.
-
What CAGR is the global pharmacogenomics (pgx) market expected to exhibit by 2033?
The global pharmacogenomics (pgx) market is expected to exhibit a CAGR of 9.3% by 2033.
-
Which are the driving factors of the Pharmacogenomics (PGx) market?
Growing Genetic Knowledge and Drug Development & Safety are drivers of this market.
-
Which are the top companies operating in the Pharmacogenomics (PGx) market?
Abbott Laboratories, Affymetrix, Inc., Assurex Health, Inc., AstraZeneca, GeneDx, Illumina, Inc., Laboratory Corporation of America Holdings (LabCorp), Myriad Genetics, Inc., Pathway Genomics, Pfizer, Inc., QIAGEN, Inc., Roche, Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific, and Transgenomic Inc are key companies operating in the Pharmacogenomics (PGx) market.